BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang M, Zhang CY. G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment. World J Gastroenterol 2021; 27(8): 677-691 [PMID: 33716447 DOI: 10.3748/wjg.v27.i8.677]
URL: https://www.wjgnet.com/1007-9327/full/v27/i8/677.htm
Number Citing Articles
1
Veronika A. Prikhodko, Natalia N. Bezborodkina, Sergey V. Okovityi. Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug CandidatesBiomedicines 2022; 10(2): 274 doi: 10.3390/biomedicines10020274
2
Lena Heinrich, Richell Booijink, Amit Khurana, Ralf Weiskirchen, Ruchi Bansal. Lipoxygenases in chronic liver diseases: current insights and future perspectivesTrends in Pharmacological Sciences 2022; 43(3): 188 doi: 10.1016/j.tips.2021.12.001
3
Xueping Li, Weijun Cui, Yanfei Cui, Xinling Song, Le Jia, Jianjun Zhang. Stropharia rugoso-annulata acetylated polysaccharides alleviate NAFLD via Nrf2/JNK1/AMPK signaling pathwaysInternational Journal of Biological Macromolecules 2022; 215: 560 doi: 10.1016/j.ijbiomac.2022.06.156
4
Chunye Zhang, Ming Yang. Current Options and Future Directions for NAFLD and NASH TreatmentInternational Journal of Molecular Sciences 2021; 22(14): 7571 doi: 10.3390/ijms22147571
5
Chengyuan Liang, Juan Li, Bin Tian, Lei Tian, Yuzhi Liu, Jingyi Li, Liang Xin, Jun Wang, Chao Fu, Zhenfeng Shi, Juan Xia, Yiting Liang, Kun Wang. Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatmentBiomedicine & Pharmacotherapy 2021; 144: 112298 doi: 10.1016/j.biopha.2021.112298
6
Chunye Zhang, Ming Yang. Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An OpinionFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.789859
7
Li-Chiung Lin, Tezz Quon, Susanna Engberg, Amanda E. Mackenzie, Andrew B. Tobin, Graeme Milligan. G Protein-Coupled Receptor GPR35 Suppresses Lipid Accumulation in HepatocytesACS Pharmacology & Translational Science 2021; 4(6): 1835 doi: 10.1021/acsptsci.1c00224
8
Chun-Ye Zhang, Shuai Liu, Ming Yang. Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progressionWorld Journal of Gastrointestinal Oncology 2022; 14(8): 1456-1468 doi: 10.4251/wjgo.v14.i8.1456
9
Youngmin A. Lee, Scott L. Friedman. Inflammatory and fibrotic mechanisms in NAFLD—Implications for new treatment strategiesJournal of Internal Medicine 2022; 291(1): 11 doi: 10.1111/joim.13380
10
Chunye Zhang, Ming Yang. Molecular targets regulating endoplasmic reticulum-mitochondria crosstalk for NAFLD treatmentExploration of Medicine 2021;  doi: 10.37349/emed.2021.00066
11
Chunye Zhang, Shuai Liu, Ming Yang. Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment OptionsFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.808526